News

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...
CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...
During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...
Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...
MUSC research to use he immune system to fight cancer shows it can be done safer, cheaper and better. An SC company pushing ...
"I won't hold my breath, because most of my patients do relapse at some point, but I was really excited about this curve when ...
AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.
Trump administration health officials assured drugmakers and researchers at a roundtable hosted by the FDA that they want to ...
A growing body of research indicates that plasma exchange therapy may slow biological aging. But do experts actually ...
The field of Cancer Immunity & Immunotherapy is entering an exciting new phase. While Volume I (see here) of this Research Topic highlighted broad ...
ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...